BETA

Activities of Anna HEDH related to 2013/0305(COD)

Shadow reports (1)

REPORT on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances PDF (439 KB) DOC (526 KB)
2016/11/22
Committee: LIBE
Dossiers: 2013/0305(COD)
Documents: PDF(439 KB) DOC(526 KB)

Amendments (8)

Amendment 33 #
Proposal for a regulation
Recital 18
(18) NOn the basis of existing evidence and on predefined criteria, no restriction measures should be introduced at Union level on new psychoactive substances which pose low health, social and safety risks.
2014/01/29
Committee: LIBE
Amendment 35 #
Proposal for a regulation
Recital 19
(19) TOn the basis of the existing evidence and on predefined criteria, those new psychoactive substances which pose moderate health, social and safety risks should not be made available to consumers.
2014/01/29
Committee: LIBE
Amendment 36 #
Proposal for a regulation
Recital 20
(20) TOn the basis of the existing evidence and on predefined criteria, those new psychoactive substances which pose severe health, social and safety risks should not be made available on the market.
2014/01/29
Committee: LIBE
Amendment 89 #
Proposal for a regulation
Article 11 – paragraph 1 – introductory part
The Commission shall not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on the following criteria, it poses, overall, low health, social and safety risks, in particular:
2014/01/29
Committee: LIBE
Amendment 99 #
Proposal for a regulation
Article 12 – paragraph 1 – introductory part
1. The Commission shall, by means of a Decision, without undue delay, prohibit the making available on the market to consumers of the new psychoactive substance if, based on the existing evidence and on the following criteria, it poses, overall, moderate health, social and safety risks, in particular:
2014/01/29
Committee: LIBE
Amendment 104 #
Proposal for a regulation
Article 13 – paragraph 1 – introductory part
1. The Commission shall, by means of a Decision, without undue delay, prohibit the production, manufacture, making available on the market including importation to the Union, transport, and exportation from the Union of the new psychoactive substance if, based on the existing evidence and on the following criteria, it poses, overall, severe health, social and safety risks, in particular:
2014/01/29
Committee: LIBE
Amendment 110 #
Proposal for a regulation
Article 13 a (new)
Article 13a Delegated acts Where the Commission considers that the criteria listed in Article 11, Article 12(1) and Article 13(1) need to be updated, amended or otherwise modified, it shall be empowered to adopt delegated acts to so amend those criteria in accordance with Article 20a of this Regulation.
2014/01/29
Committee: LIBE
Amendment 121 #
Proposal for a regulation
Article 20 a (new)
Article 20a Exercise of the delegation 1. The power to adopt delegated acts is conferred on the Commission subject to the conditions laid down in this Article. 2. The delegation of power referred to in this Regulation shall be conferred on the Commission for a period of ten years from the entry into force of this Regulation. The Commission shall draw up a report in respect of the delegation of power not later than nine months before the end of the ten year period. The delegation of powers shall be tacitly extended for a further period of ten years, unless the European Parliament or the Council opposes such extension not later than three months before the end of each period. 3. The delegation of powers referred to in this Regulation may be revoked at any time by the European Parliament or by the Council. A decision to revoke shall put an end to the delegation of the power specified in that decision. It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein. It shall not affect the validity of any delegated acts already in force. 4. As soon as it adopts a delegated act, the Commission shall notify it simultaneously to the European Parliament and to the Council. 5. A delegated act adopted pursuant to this Regulation shall enter into force only if no objection has been expressed either by the European Parliament or the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object. That period shall be extended by two months at the initiative of the European Parliament or the Council.
2014/01/29
Committee: LIBE